Delivering antigens, enzymes or genomic editors encoded by mRNA is rapidly becoming a promising programmable modality for the development of next generation vaccines and therapeutics. Landmark Bio provides a range of services designed to help advance your mRNA-based drugs to the clinic.
From determining the appropriate scale and delivery vehicle for your nucleic acid cargo to the large-scale manufacturing of mRNA and nanoparticles, our expertise ensures that your innovative therapies can reach their full potential.